Based on comprehensive analyst evaluations, we have synthesized critical insights from expert assessments to outline a cautious outlook for HIVE. Analysts note deteriorating fundamentals and challenging market sentiment, indicating potential downside risks in the near term. Following this expert analysis, we adopt a bearish stance on this stock. Our conclusion: HIVE is a Sell candidate.
HIVE price ended at $0.075794 on 星期日, after rising 2.59%
On Feb 15, 2026 00:00, the price of HIVE rose by 2.59%, climbing from $0.073780 to $0.075794 with 24h trading volume reaching $1.9M HIVE.